#USA #Boca Raton #Amplio Spine #KeyLift #TJ Jackson

Amplio Spine Welcomes TJ Jackson as Executive Vice President

Amplio Spine, a pioneering force in the medical device sector, has recently made headlines with the appointment of TJ Jackson as the Executive Vice President of Sales and Commercialization. This strategic move signals a significant step toward enhancing the company's growth strategy, particularly for its innovative KeyLift® platform, known for its unique design in interlaminar stabilization.

Who is TJ Jackson?

With over 19 years of extensive experience in the medical device industry, Jackson brings a wealth of knowledge in various areas, including spine health, interventional pain, interventional radiology, and wound care. His impressive background equips him to spearhead Amplio Spine’s national commercialization efforts. Jackson’s responsibilities will include developing the distribution network, fostering relationships with physicians and key opinion leaders, and ensuring revenue accountability aligned with Amplio’s growth objectives.

In a recent statement, Josh Lambert, Amplio Spine's founder and CEO, emphasized Jackson's impressive track record, saying, “TJ has spent his career building the commercial engines that turn differentiated technology into durable market presence.” This endorsement highlights Jackson’s track record of earning physician trust and building robust, high-performing sales teams.

Significance of the KeyLift® Platform

The KeyLift® platform is an innovative solution tailored for spine and pain management physicians, featuring an expandable interlaminar stabilization device. This product not only boasts a slim insertion profile but also offers 4 mm of controlled distraction once implanted. This capability is essential for achieving the desired anatomical corrections. Jackson stated, “KeyLift is engineered to provide a differentiated option for physicians, combining clinical efficacy with ease of use.”

The platform's importance is underscored by its FDA clearance as a supplemental fixation device for assisting fusion when used with bone graft material, proving its robustness and relevance in the current medical landscape.

As interest in KeyLift grows rapidly among spine and interventional pain specialists, Amplio Spine is proactively aligning its commercial strategies and execution capabilities to facilitate disciplined national expansion.

Jackson's Previous Experience

Before joining Amplio Spine, Jackson held the position of South Regional Vice President at Premia Spine, where he contributed to the commercialization of the TOPS™ System. His leadership extends across prominent organizations such as Spinal Simplicity, Organogenesis, Cardiovascular Systems, and Medtronic/Kyphon. His ability to lead teams to success is evidenced by his record of winning the President’s Club award six times, reflecting his commitment to developing markets and delivering innovative technologies to the medical community.

About Amplio Spine

Amplio Spine, LLC, a founder-led medical device company, is headquartered in Boca Raton, Florida. The firm focuses on developing unique technologies aimed at spinal stabilization and supplemental fusion. By collaborating closely with healthcare professionals and adhering to disciplined execution strategies, Amplio aims to stay at the forefront of the medical device industry. The KeyLift® platform is explicitly designed to address the evolving needs of neurosurgeons, orthopedic spine surgeons, and interventional spine specialists, establishing a strong foundation for future growth. For more information on Amplio Spine and their innovative solutions, you can visit their website at ampliospine.com.